Teva Pharmaceuticals recalled one lot of Metoclopramide after learning some bottles had a tablet of Torsemide. The FDA classified this as a Class II recall.

Americares, in partnership with the Healthcare Distribution Alliance, presented its annual Power of Partnership Award to Teva Pharmaceuticals in recognition of its outstanding commitment to ...

Teva 2024 Healthy Future Report: Health System Strengthening and Capacity Building Published 06-09-25 Submitted by Teva Pharmaceutical Patient who is part of the Global Hope Program in Uganda At Teva, ...

Our main initiatives in 2024 to promote health system strengthening and capacity-building were: Malawi, Uganda, Botswana, Tanzania and Rwanda - Pediatric oncology specialists are few and far ...

Teva Pharmaceuticals continues to beat consensus estimates, has once again raised its 2025 financial guidance and secured credit upgrades. Read more on why TEVA stock is a Buy.

Teva Pharmaceuticals' credit rating upgraded to BB+ by Fitch, reflecting debt reduction and positive growth outlook.

We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Substack by Kontra. In this article, we will summarize the bulls’ thesis on TEVA.

A recommendation upgrade from a veteran investment bank put some real zip in the shares. The analyst behind the change is now bullish on Teva's future. The person behind the modification was ...

A positive change in recommendation from a well-known bank was the fuel propelling Teva Pharmaceutical Industries's (NYSE: TEVA) well higher on Monday. The company, known for being a top producer ...

Teva Pharmaceuticals and Alvotech announced that the Food and Drug Administration has approved Selarsdi (ustekinumab-aekn) injection as interchangeable with Stelara (ustekinumab). As of April 30 ...

Shares of Teva Pharmaceutical (TEVA 0.12%) are surging on Wednesday. The company's stock is up 9.2% as of 1:15 p.m. ET and was up as much as 9.5% earlier in the day. The leg up comes as the S&P ...